<DOC>
	<DOC>NCT01919710</DOC>
	<brief_summary>Safety and efficacy studies of rHSA/GCSF fusion protein for injection in treatment of neutropenia induced by chemotherapy of cancer patients.</brief_summary>
	<brief_title>Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia</brief_title>
	<detailed_description>A dosage climbing for the safety and efficacy studies for the neutropenia induced by chemotherapy cancer patients Repeat-dose studies for the safety and efficacy studied for the neutropenia.</detailed_description>
	<mesh_term>Neutropenia</mesh_term>
	<criteria>chemotherapy induced neutropenia treated with other biological drugs or other neutropenia therapy drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Neutropenia</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>rHSA/GCSF</keyword>
</DOC>